AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Koninklijke Philips N.V.

Earnings Release Oct 21, 2013

3876_ir_2013-10-21-123600_b8f88b1c-c1df-4a37-a9d3-269520d48449.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

Q3 2013 Quarterly report

Philips reports third-quarter comparable sales growth of 3% to EUR 5.6 billion; operational results improve by 33% to EUR 634 million

  • Comparable sales in growth geographies up 10%
  • EBITA increased to EUR 562 million, or 10.0% of sales, compared to 6.3% in Q3 2012
  • EBITA excluding restructuring and other charges increased to EUR 634 million, or 11.3% of sales
  • Net income increased to EUR 281 million, compared to EUR 105 million in Q3 2012
  • Free cash flow amounted to EUR 117 million
  • New EUR 1.5 billion share buy-back program starts on October 21

Frans van Houten, CEO:

"This was anothersolid quarterfor Philips, especially in light of the challenging global economic environment. I am pleased with the 33% increase in our operational results, clearly reflecting the continuing benefits of our Accelerate! program. At Healthcare, EBITA improved while sales were flat and order intake declined by 2%. Consumer Lifestyle continued its strong sales performance with a comparable sales growth of 9%, driven by our focus on locally relevant products. At Lighting, LED-based sales grew 33% over the previous year, leading to an overall growth of 3%.

We continued to make good progress on the Accelerate! journey. Our overhead cost reduction program has resulted in EUR 856 million in total gross savings to date, including EUR 183 million realized in Q3 2013. Our End2End programs are delivering strong results. The leaning-out of the supply chain hasled to a reduction of inventory. Our Design for Excellence (DfX) program is building a strong funnel of opportunities to lower cost of goods sold in the coming years. End2End also enables us to deliver more locally relevant innovations faster to our customers. We see strong positive engagement from our employees, making us more agile and entrepreneurial.

Our strategic focus on value-accretive innovations and new business models is resulting in encouraging successes across our markets. Asthe leaderin the growing image-guided interventions and therapy market, Philips wasthe first company to install an advanced hybrid operating room in a leading medical institute in Moscow, which will serve as an example for other hospitals in Russia. Building on our leadership in digital innovation, we recently unveiled a range of higher-value connected consumer products,such as a smart air purifier, baby monitor and a digital grooming guide. As the global leader in energy-efficient lighting, we have been selected to transform Dubai Municipality's buildings with intelligent LED solutions. Our lighting solutions are saving 50% in electricity usage and will advance Dubai's mission to become the most sustainable city in the world.

We remain committed to reaching our financial targets this year. However, ongoing headwinds in the global economy are expected to continue to affect sales growth in the coming quarters.

Q3 financials: Operational results improve significantly across all sectors.

Healthcare currency-comparable equipment orderintake declined by 2% year-on-year, with lower orderintake at Patient Care & Clinical Informatics, while Imaging Systems recorded a slight increase. Comparable sales were flat year-on-year. Growth at Customer Services, Home Healthcare Solutions and Patient Care & Clinical Informatics was offset by a decline at Imaging Systems. In growth geographies, comparable sales increased by 3%, with strong growth in China, Central & Eastern Europe and Latin America. EBITA margin excluding restructuring and acquisition-related charges increased by 2.0 percentage points year-on-year to 14.6%.

Consumer Lifestyle comparable sales increased by 9%, with all businesses, i.e. Health & Wellness, Domestic Appliances and Personal Care, recording good growth. In the growth geographies, comparable sales registered a strong double-digit increase. EBITA margin excluding restructuring and acquisition-related charges increased to 11.1%, a year-on-year improvement of 3.0 percentage points.

Lighting comparable sales increased by 3%, led by Lumileds, Automotive and Light Sources & Electronics. Comparable sales at Professional Lighting Solutions and Consumer Luminaires declined in the quarter. LED-based sales grew by 33% and now represent 30% of total Lighting sales. In the growth geographies, comparable sales showed a double-digit increase. EBITA margin excluding restructuring and acquisition-related charges was 10.2%, a year-on-year improvement of 3.9 percentage points.

The new EUR 1.5 billion share buy-back program starts on October 21.

Please refer to page 21 of this press release for more information about forward-looking statements, third-party market share data, use of non-GAAP information and use of fair-value measurements.

Philips Group

Net income

in millions of euros unless otherwise stated

Q3 Q3
2012 2013
Sales 5,821 5,618
EBITA 366 562
as a % of sales 6.3 10.0
EBIT 254 464
as a % of sales 4.4 8.3
Financial income (expenses) (116) (92)
Income taxes (37) (108)
Results investments in associates (6) 6
Net income from continuing operations 95 270
Discontinued operations 10 11
Net income 105 281
Net income attributable to shareholders per
common share (in euros) - diluted
0.11 0.31

Sales by sector

in millions of euros unless otherwise stated

Q3 Q3 % change
2012 2013 nominal comparable
Healthcare 2,443 2,258 (8) 0
Consumer Lifestyle 1,051 1,091 4 9
Lighting 2,139 2,084 (3) 3
Innovation, Group &
Services 188 185 (2) (7)
Philips Group 5,821 5,618 (3) 3

Net income

  • Net income amounted to EUR 281 million, an increase of EUR 176 million year-on-year, which reflected better operating results across all sectors.
  • EBITA amounted to EUR 562 million, or 10.0% of sales, an increase of EUR 196 million year-on-year. Q3 2013 included a settlement loss of EUR 31 million arising from a lump-sum offering to terminated vested employeesin our US pension plan and EUR 41 million of restructuring and acquisition-related charges. Q3 2012 EBITA included a loss of EUR 34 million on the sale of industrial assets at Lighting and restructuring and acquisition-related charges of EUR 76 million.
  • EBITA, excluding restructuring and acquisition-related charges, the Q3 2013 pension settlement loss, and the Q3 2012 loss on the sale of industrial assets at Lighting, improved to EUR 634 million, or 11.3% of sales, compared to EUR 476 million, or 8.2% of sales, in Q3 2012.
  • Tax charges were EUR 71 million higher than in Q3 2012, mainly due to higher taxable earnings.
  • Income from discontinued operations, which mainly represents the results of the Television business and the Audio, Video, Multimedia and Accessories (AVM&A) business, increased by EUR 1 million year-onyear to EUR 11 million.

Sales per sector

  • Group sales amounted to EUR 5,618 million, an increase of 3% on a comparable basis. Group nominal sales decreased by 3%,reflecting a 6% negative currency effect.
  • Healthcare comparable sales remained flat year-onyear. Customer Services achieved mid-single-digit growth, while Home Healthcare Solutions and Patient Care & Clinical Informatics showed low-single-digit growth. Imaging Systems recorded a mid-single-digit decline.
  • Consumer Lifestyle comparable sales increased by 9%. Strong double-digit comparable sales growth was seen at Health & Wellness, while Domestic Appliances showed high-single-digit growth and Personal Care recorded mid-single-digit growth.
  • Lighting comparable sales were 3% higher year-on-year, led by double-digit growth at Lumileds and Automotive. Light Sources & Electronics achieved low-single-digit growth, while Professional Lighting Solutions and Consumer Luminaires recorded a low-single-digit decline.

Sales per geographic cluster

in millions of euros unless otherwise stated

Q3 Q3 % change
2012 2013 nominal comparable
Western Europe 1,402 1,382 (1) (1)
North America 1,852 1,710 (8) (2)
Other mature geographies 524 434 (17) (1)
Total mature geographies 3,778 3,526 (7) (1)
Growth geographies 2,043 2,092 2 10
Philips Group 5,821 5,618 (3) 3

Sales per geographic cluster

  • Growth geographies delivered a double-digit comparable sales increase for the second consecutive quarter, driven by higher sales in all sectors.
  • Comparable salesin mature geographies declined by 1% compared to Q3 2012. The decrease was attributable to Healthcare and Lighting, while Consumer Lifestyle showed a mid-single-digit improvement.

EBITA

in millions of euros

Q3 Q3
2012 2013
Healthcare 305 329
Consumer Lifestyle 78 116
Lighting 32 177
Innovation, Group & Services (49) (60)
Philips Group 366 562

EBITA

as a % of sales

Q3 Q3
2012 2013
Healthcare 12.5 14.6
Consumer Lifestyle 7.4 10.6
Lighting 1.5 8.5
Innovation, Group & Services (26.1) (32.4)
Philips Group 6.3 10.0

Restructuring and acquisition-related charges

in millions of euros

Q3 Q3
2012 2013
Healthcare (3) (1)
Consumer Lifestyle (7) (5)
Lighting (68) (36)
Innovation, Group & Services 2 1
Philips Group (76) (41)

EBIT

in millions of euros unless otherwise stated

Q3 Q3
2012 2013
255 283
63 102
(14) 140
(50) (61)
254 464
4.4 8.3

Earnings per sector

  • Healthcare EBITA increased by EUR 24 million year-onyear. Excluding restructuring and acquisition-related charges, EBITA improved by EUR 22 million, driven by improved gross margins and overhead cost reductions.
  • Consumer Lifestyle EBITA increased by EUR 38 million year-on-year. Excluding restructuring and acquisitionrelated charges, EBITA improved by EUR 36 million. The higher EBITA was largely attributable to operating leverage from higher sales and improved gross margins across all businesses.
  • Lighting EBITA increased by EUR 145 million year-onyear. Excluding restructuring and acquisition-related charges and the Q3 2012 loss on the sale of industrial assets, EBITA improved by EUR 79 million, driven by higher gross margins and cost reductions.
  • Innovation, Group & Services EBITA decreased by EUR 11 million to a net cost of EUR 60 million. EBITA, excluding restructuring charges and a settlement loss of EUR 31 million arising from a lump-sum offering to terminated vested employees in our US pension plan, improved by EUR 21 million compared to Q3 2012. The improvement was mainly driven by lower litigation and patent filing costs in IP Royalties.

Financial income and expenses in millions of euros

Q3 Q3
2012 2013
Net interest expenses (85) (61)
Value adjustment to option in the UK
pension plan
(12) (12)
Other (19) (19)
(116) (92)

Cash balance

in millions of euros

Q3 Q3
2012 2013
Beginning cash balance 3,134 2,307
Free cash flow 410 117
Net cash flow from operating activities 648 337
Net capital expenditures (238) (220)
Acquisitions of businesses (18) (5)
Other cash flow from investing activities (18) (6)
Treasury shares transactions (135) (18)
Dividend paid 1 (41)
Changes in debt/other (142) (237)
Net cash flow discontinued operations (83)
Ending balance 3,232 2,034

Cash flows from operating activities

in millions of euros

Financial income and expenses

• Financial income and expenses amounted to a net expense of EUR 92 million, an improvement of EUR 24 million compared with Q3 2012. This was mainly attributable to lower interest expenses on debt.

Cash balance

  • The Group cash balance decreased during Q3 2013 to EUR 2,034 million. A free cash inflow of EUR 117 million was more than offset by a EUR 237 million outflow, mainly related to debt redemption, and a EUR 83 million outflow related to discontinued operations.
  • In Q3 2012, the cash balance increased to EUR 3,232 million, mainly from a free cash inflow of EUR 410 million, partly offset by an outflow of EUR 142 million, mainly related to debt redemption, and the use of EUR 135 million in treasury sharestransactions, primarily for our share buy-back program.

Cash flows from operating activities

• Operating activitiesresulted in a cash inflow of EUR 337 million, compared to an inflow of EUR 648 million in Q3 2012. The Q3 2013 figure includes a net increase in working capital of EUR 357 million, compared to a net decrease in working capital of EUR 139 million in Q3 2012. The remaining difference compared to Q3 2012 is mainly attributable to higher earnings.

Gross capital expenditures1)

in millions of euros

Inventories

1) sales is calculated over the preceding 12 months

Gross capital expenditure

• Gross capital expenditures on property, plant and equipment were EUR 7 million lower than in Q3 2012, mainly due to lower investments at Lighting and IG&S.

Inventories

  • Inventory value at the end of Q3 2013 was EUR 3.8 billion and amounted to 16.5% of sales.
  • Compared to Q3 2012, inventories as a percentage of sales improved by 0.4 percentage points. This was mainly driven by reductions at Healthcare.

Net debt and group equity

  • At the end of Q3 2013, Philips had a net debt position of EUR 2.0 billion, compared to EUR 1.5 billion at the end of Q3 2012. During the quarter, the net debt position decreased by EUR 72 million, largely due to debt redemption.
  • Group equity increased by EUR 149 million in the quarter to EUR 11.0 billion. The increase was largely a result of net income earned during the period, partially offset by negative currency translation differences.

Number of employees in FTEs

1) Number of employees excludes discontinued operations. Discontinued operations, comprising the Audio, Video, Multimedia and Accessories business, had 1,940 employees at end of Q3 2013 (Q3 2012: 2,058; Q2 2013: 1,958).

Employees

  • Compared to Q3 2012, the number of employees decreased by 4,900. This decrease includes 327 employees from divestments. Excluding divestments, the number of employees decreased by 4,573, mainly due to the company's overhead reduction program and the industrial footprint rationalization at Lighting.
  • The number of employees decreased by 955 in the quarter, largely attributable to the rationalization of the industrial footprint at Lighting.

Healthcare

Key data

in millions of euros unless otherwise stated

Q3 Q3
2012 2013
Sales 2,443 2,258
Sales growth
% nominal 18 (8)
% comparable 7 0
EBITA 305 329
as a % of sales 12.5 14.6
EBIT 255 283
as a % of sales 10.4 12.5
Net operating capital (NOC) 8,261 7,525
Number of employees (FTEs) 38,228 37,569

in millions of euros

EBITA

Business highlights

  • Philips launched its premium EPIQ ultrasound system in Europe, parts of Asia and the US. EPIQ features high image quality paired with 'Anatomical Intelligence', a decision support technology designed to improve patient outcomes and enhance clinical workflows across the continuum of care.
  • Expanding its Hospital to Home activities in Asia Pacific, Philips has established the regional headquartersforthis business in Singapore. Philips also collaborated with Guardian Health & Beauty, Singapore's largest health and beauty chain, to screen citizens across the country for obstructive sleep apnea (OSA), to identify and treat this disorder.
  • Building on its leadership in image-guided interventions and therapy, Philips has installed an advanced hybrid operating room (OR), the first of its kind in Russia, at a leading medical institute in Moscow. The hybrid OR enables clinicians to optimally perform a wide range of clinical procedures and improve patient care.
  • In line with its vision to use partnerships to help create the future of health care, Philips strengthened its collaboration with Hansen Medical for robotic systems in minimally invasive interventions, while Froedtert & The Medical College of Wisconsin Clinical Cancer Center joined the Elekta and Philips research consortium on MRI-guided radiation therapy.
  • Reflecting the company's focus on long-term partnerships to support innovative and affordable care, Philips and Medical Center Leeuwarden in the Netherlands have signed a 10-year managed services agreement for ultrasound.

Financial performance

• Currency-comparable equipment orders declined 2% year-on-year. Patient Care & Clinical Informatics recorded a 7% decline, while Imaging Systems showed low-single-digit growth. Equipment order intake in growth geographies showed a low-single-digit decline, mainly due to Russia & Central Asia, while China and India recorded double-digit growth. North America equipment order intake showed a low-single-digit decline. Western Europe recorded a 7% decline as Q3 2012 included large and multi-year deals in the Netherlands and UK.

  • Healthcare comparable sales remained flat year-onyear. Customer Services achieved mid-single-digit growth, while Home Healthcare Solutions and Patient Care & Clinical Informatics showed low-single-digit growth. Imaging Systems recorded a mid-single-digit decline.
  • From a regional perspective, comparable sales in growth geographies increased by 3% year-on-year, with strong growth in China, Central & Eastern Europe and Latin America, partly offset by declines in Russia, Central Asia, Middle East and Turkey. Western Europe remained in line with Q3 2012, while North America declined by 2% and other mature geographies recorded low-single-digit growth.
  • EBITA was EUR 329 million, or 14.6% of sales, compared to EUR 305 million, or 12.5% of sales, in Q3 2012.
  • Excluding restructuring and acquisition-related charges, EBITA amounted to EUR 330 million, or 14.6% of sales, compared to EUR 308 million, or 12.6% of sales, in Q3 2012. The 2.0 percentage points increase was due to improved gross margins and overhead cost reductions.
  • Net operating capital, excluding a negative currency translation effect of EUR 547 million, decreased by EUR 189 million to EUR 7.5 billion. This decrease was largely driven by lower fixed assets. Inventories as a percentage of sales improved by 1.2 percentage points year-on-year, driven by reductions in all businesses.
  • Compared to Q3 2012, the number of employees decreased by 659, mainly as a result of reductions in North America and Europe.

Miscellaneous

• Restructuring and acquisition-related charges in Q4 2013 are expected to total approximately EUR 5 million.

Consumer Lifestyle*

*Excluding the Audio, Video, Multimedia and Accessories business

Key data

in millions of euros unless otherwise stated

Q3 Q3
2012 2013
Sales 1,051 1,091
Sales growth
% nominal 18 4
% comparable 10 9
EBITA 78 116
as a % of sales 7.4 10.6
EBIT 63 102
as a % of sales 6.0 9.3
Net operating capital (NOC) 1,443 1,164
Number of employees (FTEs) 17,125 16,326

in millions of euros

200

■-EBITA in millions of euros----EBITA as a % of sales

Business highlights

  • Building its leadership in digital innovation, Philips unveiled a range of consumer connected propositions at this year's IFA in Berlin. Highlights included a smart air purifier, baby monitor and a digital grooming guide.
  • The extended Philips AVENT Natural infant feeding range was showcased at the Kind + Jugend fair in Germany. The Natural baby bottle is proven to be more easily accepted by babies, thanks to its unique teat design, and has enabled Philips AVENT to achieve the #1 market position in baby bottles in North America.
  • Further strengthening our global leadership, the latest introductions in Oral Healthcare, including the Philips Sonicare PowerUp and Sonicare Flexcare Platinum, have been well received by consumers and are driving strong growth in North America and China.
  • Continuing the geographical expansion and localization of proven product innovations, Philips introduced the Airfryer in Japan and the SoupMaker in Latin America. Additionally, following major success in Russia, the MultiCooker is being launched in several European markets, with initial market response exceeding expectations.
  • Innovative, precision tools are driving Philips' market share and brand preference in male grooming. Following the successful launch of the Click & Style range, Q3 2013 saw further portfolio expansion with the introduction of the world's first laser-guided beard trimmer.

Financial performance

  • Consumer Lifestyle comparable sales increased by 9%. Strong double-digit comparable sales growth was seen at Health & Wellness, while Domestic Appliances showed high-single-digit growth and Personal Care recorded mid-single-digit growth.
  • From a regional perspective, Consumer Lifestyle achieved a strong double-digit comparable sales increase in growth geographies and mid-single-digit growth in mature geographies. North America showed high-single-digit growth, while Western Europe remained in line with Q3 2012.
  • EBITA amounted to EUR 116 million, or 10.6% of sales, an increase of EUR 38 million and 3.2 percentage points compared to Q3 2012.

  • Excluding restructuring and acquisition-related charges, EBITA was EUR 121 million, or 11.1% of sales, compared to EUR 85 million, or 8.1% of sales, in Q3 2012. The improvement of 3.0 percentage points was largely attributable to operating leverage from higher sales and improved gross margins across all businesses.

  • EBITA included EUR 7 million of net costs formerly reported in discontinued businesses (Q3 2012 included EUR 9 million related to the Audio, Video, Multimedia and Accessories business and EUR 7 million related to the Television business).
  • Net operating capital, excluding a negative currency translation effect of EUR 79 million, decreased by EUR 200 million year-on-year. The decrease was largely driven by lower working capital.
  • The number of employees decreased by 799 year-onyear, as a result of the seasonal outflow of temporary industrial personnel, mainly in the Domestic Appliances business in the Asian region.

Miscellaneous

• Restructuring and acquisition-related charges in Q4 2013 are expected to total approximately EUR 5 million.

Lighting

Key data

in millions of euros unless otherwise stated

Q3 Q3
2012 2013
Sales 2,139 2,084
Sales growth
% nominal 13 (3)
% comparable 4 3
EBITA 32 177
as a % of sales 1.5 8.5
EBIT (14) 140
as a % of sales (0.7) 6.7
Net operating capital (NOC) 5,051 4,668
Number of employees (FTEs) 51,751 47,875

in millions of euros

EBITA

Business highlights

  • By partnering with The Home Depot and utility companies, Philips has made its 60-watt-equivalent LED bulb available for less than \$5 in several states in the US.
  • As the global leader in LED lighting, Philips has been selected to transform Dubai Municipality's buildings with intelligent LED solutions, saving 50% in energy usage and helping Dubai in its mission to become the most sustainable city in the world.
  • Philips has signed a contract with Pep Boys, the US automotive aftermarket tire and service retail chain, to be its primary supplier of car lamp and LED interior/ exterior replacement lighting.
  • Driving innovation in professional lighting systems, Philips will install energy-efficient LED lighting in 170 Z-Energy petrol stations in New Zealand. Z-Energy petrol stations will reduce their total energy use by more than 11% and cut the annual carbon emissions from Z'sretail operations by 16%.
  • Enabling social and economic development by extending the hours of light in rural communities, Philips is teaming up with the Royal Netherlands Football Association (KNVB) to create 26 solarpowered LED 'Community Light Centers' in Ghana.

Financial performance

  • Comparable sales were 3% higher year-on-year, led by double-digit growth at Lumileds and Automotive. Light Sources & Electronics achieved low-single-digit growth, while Professional Lighting Solutions and Consumer Luminaires recorded a low-single-digit decline.
  • From a regional perspective, comparable sales showed a double-digit increase in growth geographies (10% increase in comparable sales excluding OEM Lumileds sales), which was partially offset by a mid-single-digit decrease in mature geographies.
  • LED-based sales grew 33% compared to Q3 2012, and now represent 30% of total Lighting sales.
  • EBITA amounted to EUR 177 million, compared to EUR 32 million in Q3 2012. Earnings in Q3 2013 were impacted by restructuring and acquisition-related charges of EUR 36 million (Q3 2012: EUR 102 million, including a EUR 34 million loss on the sale of industrial assets). The year-on-year EBITA increase was driven by higher gross margins and improvements in the cost structure.

  • EBITA, excluding restructuring and acquisition-related charges and other losses, was EUR 213 million, or 10.2% of sales (Q3 2012: EUR 134 million, or 6.3% of sales). Light Sources & Electronics, Professional Lighting Solutions and Lumileds were the main contributors to the operational improvement.

  • Net operating capital, excluding a negative currency translation effect of EUR 227 million, decreased by EUR 156 million year-on-year. The decrease was largely driven by provisions and lower fixed assets.
  • Inventories as a percentage of sales improved by 0.2 percentage points year-on-year.
  • Compared to Q3 2012, the number of employees decreased by 3,876, mainly due to the rationalization of the industrial footprint.

Miscellaneous

• Restructuring and acquisition-related charges in Q4 2013 are expected to total approximately EUR 20 million.

Innovation, Group & Services

Key data

in millions of euros unless otherwise stated

Q3 Q3
2012 2013
Sales 188 185
Sales growth
% nominal 19 (2)
% comparable 16 (7)
EBITA of:
Group Innovation (33) (28)
IP Royalties 63 82
Group and Regional Costs (38) (33)
Accelerate! investments (33) (34)
Pensions 1 (32)
Service Units and Other (9) (15)
EBITA (49) (60)
EBIT (50) (61)
Net operating capital (NOC) (3,707) (3,108)
Number of employees (FTEs) 12,122 12,556

Sales

in millions of euros

EBITA

Business highlights

  • Philips improved its brand ranking by one position to become the 40th most valuable brand in the top-100 global brands by Interbrand. The brand value of Philips increased by 8% to close to USD 10 billion.
  • Philips received 510(k) clearance from the US Food and Drug Administration to bring to the US market its first Digital Pathology product for a digital manual read of HER2 status for patients with invasive breast cancer. Assessment of HER2 is a standard test to evaluate treatment options.
  • Philips was recognized as a leader in the Carbon Disclosure Project for the third consecutive year on both performance and disclosure.
  • Philips received a total of eight Successful Design Awards China 2013. Five of the winners were for Philips health care solutions, with the highest honor of the 'Diamond Award' going to the Philips Ambient Experience Electro Physiology Lab.
  • Underscoring its innovation in lighting technology, Philips has collaborated with Audi, Merck KGaA, Automotive Lighting and the University of Cologne in a research consortium to create the world's first largearea, 3D organic light-emitting diodes (OLEDs); these OLEDs have now been applied in the rear lighting of a vehicle for the first time.

Financial performance

  • Sales decreased marginally from EUR 188 million in Q3 2012 to EUR 185 million in Q3 2013.
  • EBITA amounted to a net cost of EUR 60 million, including a EUR 31 million settlement loss arising from a lump-sum offering to terminated vested employees in our US pension plan. Net restructuring charges in Q3 2013 amounted to a release of EUR 1 million (Q3 2012: a net release of EUR 2 million).
  • EBITA, excluding restructuring charges and the EUR 31 million pension settlement loss, improved by EUR 21 million compared to Q3 2012, mainly due to lower litigation and patent filing costs in IP Royalties.
  • EBITA of Service Units and Other included EUR 19 million of net costs formerly reported in discontinued businesses (Q3 2012 included EUR 9 million related to the Audio, Video, Multimedia and Accessories business and EUR 3 million related to the Television business).

  • Compared to Q3 2012, the number of employees increased by 434, primarily due to the centralization of Human Resource and Research activities, partly offset by restructuring activities in the Service Units.

  • Net operating capital, excluding a currency translation effect of EUR 101 million, increased by EUR 498 million year-on-year, mainly due to an increase in the value of currency hedges.

Miscellaneous

• Restructuring charges in Q4 2013 are expected to total approximately EUR 5 million.

Additional information on Audio, Video, Multimedia and Accessories business

AVM&A results reconciliation

in millions of euros unless otherwise stated

Q3 Q3
2012 2013
EBITA 2 (9)
Disentanglement costs 0 (12)
Former AVM&A net costs allocated to
Consumer Lifestyle
9 7
Former AVM&A net costs allocated to IG&S 9 19
Eliminated amortization other AVM&A
intangibles
(4) 0
EBIT discontinued operations 16 5
Financial income and expenses 0 1
Income taxes (6) 4
Net income (loss) of discontinued
operations
10 10
Number of employees (FTEs) 2,058 1,940

Following the agreement with Funai Electric Co. Ltd, as mentioned in the Q1 2013 pressrelease, the results of the Audio, Video, Multimedia and Accessories (AVM&A) business are reported as discontinued operations in the Consolidated statements of income and Consolidated statements of cash flows. Prior-period comparative figures have been restated accordingly. Consequently, Audio, Video, Multimedia and Accessories sales and EBITA are no longer included in the Consumer Lifestyle and Group results of continuing operations.

The net income of discontinued operations attributable to the Audio, Video, Multimedia and Accessories business is in line with Q3 2012 at EUR 10 million.

Since Q1 2013, the applicable net operating capital of this business is reported under Assets and Liabilities classified as held for sale in the Consolidated balance sheet.

The EBITA of Consumer Lifestyle includes net costs of EUR 7 million formerly reported as part of the results of this business. The EBITA of Innovation, Group & Services includes net costs of EUR 19 million formerly reported as part of this business.

Other information

Share repurchase program

Philips will start a share repurchase program of up to EUR 1.5 billion to be executed during the next 2-3 years. The maximum number of shares that will be repurchased under this program depends on the development in the share price during the course of the program. All shares repurchased under this program will be cancelled, resulting in a reduction of Philips' outstanding share capital.

Philips willstart thisrepurchase program as of October 21 and will enter into subsequent discretionary management agreements with one or more banks to repurchase Philips shares within the limits ofrelevant laws and regulations(in particular EC Regulation 2273/2003) and Philips' articles of association. All transactions under this program will be published on Philips' website (www.philips.com/investor) on a weekly basis.

Philips quarterly statistics

all amounts in millions of euros unless otherwise stated

2012 2013
1st quarter 2nd quarter 3rd quarter 4th quarter 1st quarter 2nd quarter 3rd quarter 4th quarter
Sales 5,307 5,570 5,821 6,759 5,258 5,654 5,618
comparable sales growth % 5 6 7 5 1 3 3
Gross margin 2,008 2,139 2,253 2,591 2,101 2,347 2,357
as a % of sales 37.8 38.4 38.7 38.3 40.0 41.5 42.0
Selling expenses (1,196) (1,314) (1,298) (1,526) (1,190) (1,245) (1,214)
as a % of sales (22.5) (23.6) (22.3) (22.6) (22.6) (22.0) (21.6)
G&A expenses (199) (151) (222) (273) (200) (230) (253)
as a % of sales (3.7) (2.7) (3.8) (4.0) (3.8) (4.1) (4.5)
R&D expenses (450) (440) (447) (494) (424) (416) (437)
as a % of sales (8.5) (7.9) (7.7) (7.3) (8.1) (7.4) (7.8)
EBIT 341 229 254 (176) 305 509 464
as a % of sales 6.4 4.1 4.4 (2.6) 5.8 9.0 8.3
EBITA 451 339 366 (50) 402 603 562
as a % of sales 8.5 6.1 6.3 (0.7) 7.6 10.7 10.0
Net income (loss) 183 102 105 (420) 162 317 281
Net income (loss) attributable to
shareholders
182 102 104 (423) 161 317 282
Net income (loss) - shareholders per
common share in euros - diluted
0.20 0.11 0.11 (0.46) 0.17 0.35 0.31

Philips quarterly statistics (continued)

all amounts in millions of euros unless otherwise stated

2012 2013
January
March
January
June
January
September
January
December
January
March
January
June
January
September
January
December
Sales
comparable sales growth %
5,307
5
10,877
6
16,698
6
23,457
6
5,258
1
10,912
2
16,530
2
Gross margin
as a % of sales
2,008
37.8
4,147
38.1
6,400
38.3
8,991
38.3
2,101
40.0
4,448
40.8
6,805
41.2
Selling expenses
as a % of sales
(1,196)
(22.5)
(2,510)
(23.1)
(3,808)
(22.8)
(5,334)
(22.7)
(1,190)
(22.6)
(2,435)
(22.3)
(3,649)
(22.1)
G&A expenses
as a % of sales
(199)
(3.7)
(350)
(3.2)
(572)
(3.4)
(845)
(3.6)
(200)
(3.8)
(430)
(3.9)
(683)
(4.1)
R&D expenses (450) (890) (1,337) (1,831) (424) (840) (1,277)
as a % sales (8.5) (8.2) (8.0) (7.8) (8.1) (7.7) (7.7)
EBIT 341 570 824 648 305 814 1,278
as a % of sales 6.4 5.2 4.9 2.8 5.8 7.5 7.7
EBITA 451 790 1,156 1,106 402 1,005 1,567
as a % of sales 8.5 7.3 6.9 4.7 7.6 9.2 9.5
Net income (loss) 183 285 390 (30) 162 479 760
Net income (loss) attributable to
shareholders
182 284 388 (35) 161 478 760
Net income (loss) - shareholders per
common share in euros - diluted
0.20 0.31 0.42 (0.04) 0.17 0.52 0.83
Net income (loss) from continuing
operations as a % of shareholders' equity
6.3 4.3 4.0 (0.6) 5.8 9.0 9.4
period ended 2012 period ended 2013
Number of common shares outstanding
(after deduction of treasury shares) at the
end of period (in thousands) 915,926 931,391 923,912 914,591 905,381 913,874 915,095
Shareholders' equity per common share in
euros
13.35 13.01 13.01 12.19 12.33 11.78 11.93
Inventories as a % of sales1) 16.9 17.2 16.9 14.3 15.5 15.7 16.5
Inventories excluding discontinued
operations
3,623 3,812 3,877 3,359 3,629 3,696 3,832
Net debt : group equity ratio 6:94 13:87 11:89 6:94 12:88 16:84 16:84
Net operating capital 10,634 11,485 11,048 9,316 9,969 10,184 10,249
Total employees
of which discontinued operations
122,008
2,285
121,801
2,166
121,284
2,058
118,087
2,005
117,881
1,970
117,239
1,958
116,266
1,940

1) sales is calculated over the preceding 12 months

Forward-looking statements

Forward-looking statements

This document and the related oral presentation, including responses to questions following the presentation, contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about our strategy, estimates of sales growth, future EBITA and future developments in our organic business. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.

These factors include but are not limited to domestic and global economic and business conditions, developments within the euro zone, the successful implementation of our strategy and our ability to realize the benefits of this strategy, our ability to develop and market new products, changes in legislation, legal claims, changes in exchange and interest rates, changes in tax rates, pension costs and actuarial assumptions, raw materials and employee costs, our ability to identify and complete successful acquisitions and to integrate those acquisitions into our business, our ability to successfully exit certain businesses or restructure our operations, the rate of technological changes, political, economic and other developments in countries where Philips operates, industry consolidation and competition. As a result, Philips' actual future results may differ materially from the plans, goals and expectations set forth in such forward-looking statements. For a discussion of factors that could cause future results to differ from such forward-looking statements, see the Risk management chapter included in our Annual Report 2012.

Third-party market share data

Statements regarding market share, including those regarding Philips' competitive position, contained in this document are based on outside sources such as research institutes, industry and dealer panels in combination with management estimates. Where information is not yet available to Philips, those statements may also be based on estimates and projections prepared by outside sources or management. Rankings are based on sales unless otherwise stated.

Use of non-GAAP information

In presenting and discussing the Philips Group financial position, operating results and cash flows, management uses certain non-GAAP financial measures. These non-GAAP financial measures should not be viewed in isolation as alternatives to the equivalent IFRS measures and should be used in conjunction with the most directly comparable IFRS measures. A reconciliation of these non-GAAP measures to the most directly comparable IFRS measures is contained in this document. Further information on non-GAAP measures can be found in our Annual Report 2012.

Use of fair-value measurements

In presenting the Philips Group financial position, fair values are used for the measurement of various items in accordance with the applicable accounting standards. These fair values are based on market prices, where available, and are obtained from sources that are deemed to be reliable. Readers are cautioned that these values are subject to changes over time and are only valid at the balance sheet date. When quoted prices or observable market data are not readily available, fair values are estimated using appropriate valuation models and unobservable inputs. Such fair value estimates require management to make significant assumptions with respect to future developments, which are inherently uncertain and may therefore deviate from actual developments. Critical assumptions used are disclosed in our Annual Report 2012. Independent valuations may have been obtained to support management's determination of fair values.

All amounts are in millions of euros unless otherwise stated. All reported data is unaudited. Financial reporting is in accordance with the accounting policies as stated in the Annual Report 2012, unless otherwise stated.

Prior-period financials have been restated for the treatment of Audio, Video, Multimedia and Accessories as discontinued operations, the adoption of IAS 19R, which mainly relates to pension reporting, and adjustments to the quarterly figures of 2012, which have already been included in the Annual Report 2012 (for an explanation refer to Annual Report 2012 section 12.10 "Significant Accounting Policies"). An overview of the revised 2012 figures per quarter is available on the Philips website, in the Investor Relations section.

Condensed consolidated statements of income

in millions of euros unless otherwise stated

3rd quarter January to September
2012 2013 2012 2013
Sales 5,821 5,618 16,698 16,530
Cost of sales (3,568) (3,261) (10,298) (9,725)
Gross margin 2,253 2,357 6,400 6,805
Selling expenses (1,298) (1,214) (3,808) (3,649)
General and administrative expenses (222) (253) (572) (683)
Research and development expenses (447) (437) (1,337) (1,277)
Other business income 9 20 241 102
Other business expenses (41) (9) (100) (20)
Income from operations 254 464 824 1,278
Financial income 13 15 62 51
Financial expenses (129) (107) (352) (304)
Income before taxes 138 372 534 1,025
Income tax expense (37) (108) (158) (298)
Income after taxes 101 264 376 727
Results relating to investments in associates (6) 6 (18) 21
Net income from continuing operations 95 270 358 748
Discontinued operations - net of income tax 10 11 32 12
Net income 105 281 390 760
Attribution of net income for the period
Net income attributable to shareholders 104 282 388 760
Net income attributable to non-controlling interests 1 (1) 2
Earnings per common share attributable to shareholders
Weighted average number of common shares outstanding
(after deduction of treasury shares) during the period (in thousands):
- basic 929,2611) 914,431 925,1121) 910,145
- diluted 936,1761) 922,209 929,4851) 917,701
Net income attributable to shareholders per common share in euros:
- basic 0.11 0.31 0.42 0.84
- diluted 0.11 0.31 0.42 0.83

1) Adjusted to make 2012 comparable for the elective share dividend premium (273 thousand) issued in June 2013

Condensed consolidated balance sheets

in millions of euros unless otherwise stated

September 30, December 31, September 29,
2012 2012 2013
Non-current assets:
Property, plant and equipment
2,992 2,959 2,813
Goodwill 7,117 6,948 6,654
Intangible assets excluding goodwill 3,902 3,731 3,400
Non-current receivables 154 176 163
Investments in associates 195 177 165
Other non-current financial assets 557 549 596
Deferred tax assets 1,837 1,919 1,826
Other non-current assets 80 94 67
Total non-current assets 16,834 16,553 15,684
Current assets:
Inventories - net 4,071 3,495 3,832
Other current financial assets 10
Other current assets 412 337 425
Derivative financial assets 129 137 138
Income tax receivable 133 97 136
Receivables 4,522 4,585 4,580
Assets classified as held for sale 56 43 486
Cash and cash equivalents 3,232 3,834 2,034
Total current assets 12,555 12,528 11,641
Total assets 29,389 29,081 27,325
Shareholders' equity 12,016 11,151 10,913
Non-controlling interests 36 34 38
Group equity 12,052 11,185 10,951
Non-current liabilities:
Long-term debt 3,837 3,725 3,374
Long-term provisions 1,969 2,119 2,011
Deferred tax liabilities 144 92 104
Other non-current liabilities 1,955 2,005 1,754
Total non-current liabilities 7,905 7,941 7,243
Current liabilities:
Short-term debt 859 809 692
Derivative financial liabilities 674 517 413
Income tax payable 142 200 119
Accounts and notes payable 2,997 2,839 3,076
Accrued liabilities 2,986 3,171 2,895
Short-term provisions 640 837 613
Liabilities directly associated with assets held for sale 33 27 245
Other current liabilities 1,101 1,555 1,078
Total current liabilities 9,432 9,955 9,131
Total liabilities and group equity 29,389 29,081 27,325

Condensed consolidated statements of cash flows

in millions of euros

3rd quarter January to September
2012 2013 2012 2013
Cash flows from operating activities:
Net income 105 281 390 760
Loss from discontinued operations (10) (11) (32) (12)
Adjustments to reconcile net income to net cash provided by operating activities:
Fixed assets depreciation, amortization, and impairments 346 330 1,016 946
Impairment of goodwill and other non-current financial assets 9 3 12 6
Net gain (loss) on sale of assets 33 (9) (159) (49)
(Income) loss from investments in associates 3 (7) 9 (22)
Dividends received from investments in associates 7 6
(Increase) decrease in working capital: 139 (357) (234) (1,247)
Increase in receivables and other current assets (206) (428) (109) (421)
Increase in inventories (157) (265) (443) (662)
Increase (decrease) in accounts payable, accrued and other liabilities 502 336 318 (164)
(Increase) decrease in non-current receivables, other assets and other liabilities (62) 60 (191) (79)
Increase (decrease) in provisions 51 (76) 107 (243)
Other items 34 123 101 167
Net cash provided by operating activities 648 337 1,026 233
Cash flows from investing activities:
Purchase of intangible assets (11) (9) (25) (17)
Proceeds from sale of intangible assets 160
Expenditures on development assets (86) (88) (250) (268)
Capital expenditures on property, plant and equipment (144) (137) (449) (406)
Proceeds from disposals of property, plant and equipment 3 14 412 22
Cash to derivatives and securities (9) (11) (54) (93)
Purchase of other non-current financial assets (9) (1) (163) (5)
Proceeds from other non-current financial assets 6 15
Purchase of businesses, net of cash acquired (22) 1 (253) (5)
Proceeds from sale of interests in businesses, net of cash disposed of 4 (6) 13 85
Net cash used for investing activities (274) (231) (609) (672)
Cash flows from financing activities:
Proceeds from issuance of (payments on) short-term debt (20) (76) 168 (203)
Principal payments on long-term debt (106) (126) (589) (167)
Proceeds from issuance of long-term debt 28 14 1,201 48
Treasury shares transactions (135) (18) (577) (505)
Dividends paid 1 (41) (255) (272)
Net cash used for financing activities (232) (247) (52) (1,099)
Net cash provided by (used for) continuing operations 142 (141) 365 (1,538)
Cash flows from discontinued operations:
Net cash used for operating activities (70) (44) (273) (176)
Net cash provided by (used for) investing activities 70 (39) 73 (50)
Net cash used for discontinued operations (83) (200) (226)
Net cash provided by (used for) continuing and discontinued operations 142 (224) 165 (1,764)
3rd quarter January to September
Effect of change in exchange rates on cash and cash equivalents (44) (49) (80) (36)
Cash and cash equivalents at the beginning of the period 3,134 2,307 3,147 3,834
Cash and cash equivalents at the end of the period 3,232 2,034 3,232 2,034
Net cash paid during the period for
Pensions (149) (157) (490) (489)
Interest (102) (83) (210) (202)
Income taxes (92) (139) (275) (378)

For a number of reasons, principally the effects of translation differences, certain items in the statements of cash flows do not correspond to the differences between the balance sheet amounts for the respective items.

Condensed consolidated statement of changes in equity

in millions of euros

common
shares
capital
in
excess
of par
value
retained
earnings
revaluation
reserve
currency
translation
differences
available
-for-sale
financial
assets
cash
flow
hedges
treasury
shares at
cost
total
sharehol
ders'
equity
non
controlling
interests
total
equity
January-September 2013
Balance as of
December 31, 2012
191 1,304 10,724 54 (93) 54 20 (1,103) 11,151 34 11,185
Net income 760 760 760
Other comprehensive
income, net of tax
(24) (12) (277) 8 (6) (311) (311)
Total comprehensive
income
736 (12) (277) 8 (6) 449 449
Dividend distributed 4 402 (678) (272) (272)
Movement non-controlling
interest
4 4
Cancellation of treasury
shares
(7) (780) 787
Purchase of treasury shares (38) (531) (569) (569)
Re-issuance of treasury
shares
(37) (58) 167 72 72
Share-based compensation
plans
74 74 74
Income tax share-based
compensation plans
8 8 8
Total other equity
movements
(3) 447 (1,554) 423 (687) 4 (683)
Balance as of
September 29, 2013
188 1,751 9,906 42 (370) 62 14 (680) 10,913 38 10,951

Sectors

in millions of euros unless otherwise stated

Sales and income from operations

3rd quarter
2012
sales income from operations sales income from operations
as a % of sales as a % of sales
Healthcare 2,443 255 10.4 2,258 283 12.5
Consumer Lifestyle 1,051 63 6.0 1,091 102 9.3
Lighting 2,139 (14) (0.7) 2,084 140 6.7
Innovation, Group & Services 188 (50) 185 (61)
Philips Group 5,821 254 4.4 5,618 464 8.3

Sales and income from operations

January to September
2012 2013
sales income from operations income from operations
as a % of sales as a % of sales
Healthcare 7,065 665 9.4 6,747 838 12.4
Consumer Lifestyle 2,934 287 9.8 3,177 255 8.0
Lighting 6,180 22 0.4 6,107 365 6.0
Innovation, Group & Services 519 (150) 499 (180)
Philips Group 16,698 824 4.9 16,530 1,278 7.7

Sectors and main countries

in millions of euros

Sales total assets and total liabilities

sales total assets total liabilities excluding debt
January to September
September 30,
September 29, September 30, September 29,
2012 2013 2012 2013 2012 2013
Healthcare 7,065 6,747 11,617 10,783 3,269 3,172
Consumer Lifestyle 2,934 3,177 3,506 3,007 2,063 1,843
Lighting 6,180 6,107 7,316 7,150 2,243 2,461
Innovation, Group & Services 519 499 6,894 5,899 5,033 4,587
29,333 26,839 12,608 12,063
Assets and liabilities classified as held for
sale 56 486 33 245
Philips Group 16,698 16,530 29,389 27,325 12,641 12,308

Sales and tangible and intangible assets

sales tangible and intangible assets1)
January to September September 30, September 29,
2012 2013 2012 2013
Netherlands 436 463 892 867
United States 4,974 4,699 8,280 7,572
China 1,847 2,045 1,122 1,093
Germany 914 926 261 282
Japan 842 761 621 439
France 663 633 89 82
India 520 493 156 126
Other countries 6,502 6,510 2,590 2,406
Philips Group 16,698 16,530 14,011 12,867

1) Includes property, plant and equipment, goodwill, and intangible assets excluding goodwill

Pension costs

in millions of euros

Specification of pension costs

3rd quarter
2012 2013
Netherlands other total Netherlands other total
Defined-benefit plans
Pensions
Current service cost 44 21 65 48 23 71
Past service cost (incl. curtailments)
Settlements 31 31
Interest expense 19 19 17 17
Interest income (1) (1) (1) (1)
Total 43 40 83 47 71 118
of which discontinued operations
Retiree Medical
Interest expense 3 3 2 2
Total 3 3 2 2
Defined-contribution plans
Cost 3 34 37 3 34 37
of which discontinued operations 1 1 1 1

Specification of pension costs

January to September
2012 2013
Netherlands other total Netherlands other total
Defined-benefit plans
Pensions
Current service cost 131 65 196 144 64 208
Past service cost (incl. curtailments) (78) (78)
Settlements 31 31
Interest expense 57 57 49 49
Interest income (3) (3) (3) (3)
Total 128 122 250 141 66 207
of which discontinued operations 1 1 2 1 1
Retiree Medical
Current service cost 1 1 1 1
Past service cost (incl. curtailments) (25) (25)
Interest expense 9 9 8 8
Total (15) (15) 9 9
Defined-contribution plans
Cost 8 101 109 7 105 112
of which discontinued operations 1 3 4 2 2

Reconciliation of non-GAAP performance measures

in millions of euros unless otherwise stated

Certain non-GAAP financial measures are presented when discussing the Philips Group's performance. In the following tables, a reconciliation to the most directly comparable IFRS performance measure is made.

Sales growth composition

in %
3rd quarter January to September
comparable
growth
currency
effects
consolidation
changes
nominal
growth
comparable
growth
currency
effects
consolidation
changes
nominal
growth
2013 versus 2012
Healthcare 0.0 (7.1) (0.5) (7.6) (0.5) (3.8) (0.2) (4.5)
Consumer Lifestyle 9.3 (5.5) 0.0 3.8 10.8 (2.5) 0.0 8.3
Lighting 3.0 (5.8) 0.2 (2.6) 1.5 (2.7) 0.0 (1.2)
Innovation, Group &
Services (6.9) (1.3) 6.6 (1.6) (8.3) (0.5) 4.9 (3.9)
Philips Group 2.5 (6.1) 0.1 (3.5) 2.0 (3.1) 0.1 (1.0)

EBITA (or Adjusted income from operations) to Income from operations (or EBIT)

3rd quarter January to September
Income from
operations (or
EBIT)
Amortization of
intangibles1)
EBITA (or Adjusted
income from
operations)
Income from
operations (or
EBIT)
Amortization of
intangibles1)
EBITA (or Adjusted
income from
operations)
2013
Healthcare 283 (46) 329 838 (133) 971
Consumer Lifestyle 102 (14) 116 255 (41) 296
Lighting 140 (37) 177 365 (112) 477
Innovation, Group &
Services
(61) (1) (60) (180) (3) (177)
Philips Group 464 (98) 562 1,278 (289) 1,567
2012
Healthcare 255 (50) 305 665 (150) 815
Consumer Lifestyle 63 (15) 78 287 (42) 329
Lighting (14) (46) 32 22 (134) 156
Innovation, Group &
Services (50) (1) (49) (150) (6) (144)
Philips Group 254 (112) 366 824 (332) 1,156

1) Excluding amortization of software and product development

Reconciliation of non-GAAP performance measures (continued)

in millions of euros

Net operating capital to total assets

Philips Group Healthcare Consumer
Lifestyle
Lighting IG&S
September 29, 2013
Net operating capital (NOC) 10,249 7,525 1,164 4,668 (3,108)
Exclude liabilities comprised in NOC:
-
payables/liabilities
9,335 2,730 1,565 1,851 3,189
-
intercompany accounts
159 79 126 (364)
-
provisions
2,624 283 199 484 1,658
Include assets not comprised in NOC:
-
investments in associates
165 86 21 58
-
other current financial assets
10 10
-
other non-current financial assets
596 596
-
deferred tax assets
1,826 1,826
-
cash and cash equivalents
2,034 2,034
26,839 10,783 3,007 7,150 5,899
Assets classified as held for sale 486
Total assets 27,325
December 31, 2012
Net operating capital (NOC) 9,316 7,976 1,205 4,635 (4,500)
Exclude liabilities comprised in NOC:
-
payables/liabilities
10,287 2,760 1,718 1,695 4,114
-
intercompany accounts
71 42 37 (150)
-
provisions
2,956 355 315 581 1,705
Include assets not comprised in NOC:
-
investments in associates
177 86 22 69
-
other non-current financial assets
549 549
-
deferred tax assets
1,919 1,919
-
cash and cash equivalents
3,834 3,834
29,038 11,248 3,280 6,970 7,540
Assets classified as held for sale 43
Total assets 29,081
September 30, 2012
Net operating capital (NOC) 11,048 8,261 1,443 5,051 (3,707)
Exclude liabilities comprised in NOC:
-
payables/liabilities
9,855 2,920 1,703 1,792 3,440
-
intercompany accounts
68 32 54 (154)
-
provisions
2,609 281 328 397 1,603
Include assets not comprised in NOC:
-
investments in associates
195 87 22 86
-
other non-current financial assets
557 557
-
deferred tax assets
1,837 1,837
-
cash and cash equivalents
3,232 3,232
29,333 11,617 3,506 7,316 6,894
Assets held for sale 56
Total assets 29,389

Reconciliation of non-GAAP performance measures (continued)

in millions of euros

Composition of net debt to group equity

September 30, December 31, September 29,
2012 2012 2013
Long-term debt 3,837 3,725 3,374
Short-term debt 859 809 692
Total debt 4,696 4,534 4,066
Cash and cash equivalents 3,232 3,834 2,034
Net debt (cash) (total debt less cash and cash equivalents) 1,464 700 2,032
Shareholders' equity 12,016 11,151 10,913
Non-controlling interests 36 34 38
Group equity 12,052 11,185 10,951
Net debt and group equity 13,516 11,885 12,983
Net debt divided by net debt and group equity (in %) 11 6 16
Group equity divided by net debt and group equity (in %) 89 94 84

Composition of cash flows

3rd quarter January to September
2012 2013 2012 2013
Cash flows provided by operating activities 648 337 1,026 233
Cash flows used for investing activities (274) (231) (609) (672)
Cash flows before financing activities 374 106 417 (439)
Cash flows provided by operating activities 648 337 1,026 233
Net capital expenditures: (238) (220) (152) (669)
Purchase of intangible assets (11) (9) (25) (17)
Proceeds from sale of intangible assets 160
Expenditures on development assets (86) (88) (250) (268)
Capital expenditures on property, plant and equipment (144) (137) (449) (406)
Proceeds from sale of property, plant and equipment 3 14 412 22
Free cash flows 410 117 874 (436)

Talk to a Data Expert

Have a question? We'll get back to you promptly.